In a Medscape review on type 2 diabetes remission, AACE President Scott D. Isaacs, MD, FACP, FACE, emphasized that remission is not the same as reversal and highlighted growing evidence that sustained lifestyle changes and modern therapies, including GLP-1 receptor agonists, can help some patients achieve and maintain remission with ongoing monitoring.